T/SDACM 004-2024 Active Group standards

T/SDACM 004-2024 Normal high blood pressure integrated intervention by traditional Chinese and Western medicine experts consensus

Publish Date: 2024-09-06 Implement Date: 2024-09-06 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/SDACM 004-2024

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: -

ICS Name: Terminology (principles and coordination and cooperation)

Publish Date: 2024-09-06

Implement Date: 2024-09-06

Scope

Main Technical Content: Normal high blood pressure, also known as borderline hypertension, refers to blood pressure values between normal blood pressure and diagnosed hypertension, namely systolic blood pressure of 120–139 mmHg and diastolic blood pressure of 80–89 mmHg. Hypertension is one of the most common chronic diseases and a major risk factor for cardiovascular and cerebrovascular diseases, which can lead to major complications such as stroke, heart failure, and chronic kidney disease, seriously affecting patients' quality of life and placing a heavy burden on families and society. Before the diagnosis of primary hypertension is established, patients typically go through a transitional period of varying lengths, namely normal high blood pressure, during which major organs such as the heart, brain, and kidneys show no structural damage but are prone to developing into hypertension. Clinical observations show that approximately 71.5% of people with normal high blood pressure are likely to develop hypertension, and the likelihood of normal high blood pressure patients developing into diagnosed hypertension is 2–5 times higher than that of normal blood pressure patients, while the risk for normal people is only 11.1%. The incidence and mortality of cardiovascular complications, including cerebral hemorrhage, cerebral thrombosis, and coronary heart disease, are more than twice as high as those of normal blood pressure patients and significantly higher than those of hypertension patients. Due to the lack of structural damage in the early stages and the absence of specific symptoms and signs, it is easily overlooked. Shifting prevention and treatment strategies forward is the current trend in clinical medicine [2,3], and normal high blood pressure is the first battlefield for hypertension [4,5]. Although there are currently guidelines for hypertension and dizziness (primary hypertension), there is still no consensus or guidelines for normal high blood pressure. Base